FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A.

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

FF

IT0005215329

Food Processing

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-07-16 am EDT			5-day change	1st Jan Change
8.9 ^EUR	-0.45%		-0.67%	+1.48%

May. 15	Fine Foods confirms profit; Capex for period over EUR5 million	AN
May. 15	Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Fine Foods & Pharmaceuticals N T M S p A : NOTIFICATION OF TREASURY SHARE BUYBACK – BETWEEN 4 JANUARY – 8 JANUARY 2021

January 13, 2021 at 12:06 pm EST

Date	Market	Purchase-	Nr.		Nr.	Value	Price	Total
Sell	Operation	Shares


04/01/2021	AIM	P	4	778	EUR	10.5771	8,229
05/01/2021	AIM	P	4	571	EUR	10.5701	6,035
06/01/2021	AIM	P	11	1,924	EUR	10.5337	20,267
07/01/2021	AIM	P	4	510	EUR	10.5500	5,380
08/01/2021	AIM	P	11	2,021	EUR	10.9147	22,059

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Original document
Permalink

Disclaimer

Fine Foods & Pharmaceuticals NTM S.p.A. published this content on 11 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2021 17:05:06 UTC

Latest news about Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Fine Foods confirms profit; Capex for period over EUR5 million	May. 15	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Emak best performer; Bialetti trailing.	Apr. 30	AN
Fine Foods narrows loss in 2023; up 22 percent in revenue	Apr. 02	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Fine Foods & Pharmaceuticals NTM takes over 2,100 shares of its own stock	Feb. 05	AN
Fine Foods & Pharmaceuticals purchases 1,600 treasury shares	Jan. 29	AN
Fine Foods & Pharmaceuticals purchases 2,000 treasury shares	Jan. 22	AN
Fine Foods & Pharmaceuticals NTM takes over 2,300 of its own shares	Jan. 15	AN
Fine Foods & Pharmaceuticals NTM takes over 2,000 shares of its own stock	Jan. 08	AN
Fine Foods & Pharmaceuticals NTM acquires 2,159 shares of its own stock	Dec. 19	AN
Fine Foods & Pharmaceuticals purchases 2,000 treasury shares	Dec. 11	AN
More buy orders on stock markets; ERG on top	Nov. 15	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 14	CI
Fine Foods & Pharmaceuticals improves loss; on revenue and Ebitda	Nov. 14	AN
Fine Foods & Pharmaceuticals NTM takes over 2,400 shares of its own stock	23-10-24	AN
Fine Foods & Pharmaceuticals NTM takes over 2,137 shares of its own stock	23-10-16	AN
Fine Foods & Pharmaceuticals NTM takes over 3,200 shares of its own stock	23-10-09	AN
Fine Foods & Pharmaceuticals purchases shares for EUR38,000	23-10-02	AN
Fine Foods & Pharmaceuticals NTM improves half-year loss	23-09-13	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-12	CI
Fine Foods & Pharmaceuticals NTM acquires more than 2,000 shares of its own stock	23-07-31	AN
Fine Foods purchased 3,476 shares of its own common stock	23-07-24	AN
Pininfarina bullish; Fine Food trailing.	23-07-21	AN
Fine Foods has purchased more than 2,500 shares of its own common stock	23-07-17	AN

Chart Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Duration

Period

Chart Fine Foods & Pharmaceuticals N.T.M. S.p.A.

More charts

Company Profile

Fine Foods & Pharmaceuticals NTM SpA, formerly Innova Italy 1 SpA, is an Italy-based pharmaceutical company. It is specialized in the manufacturing of pharmaceutical products for third parties. The Company manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

Sector

Food Processing

Calendar

2024-09-12 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.94 EUR

Average target price

12.25 EUR

Spread / Average Target

+37.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A.	+1.48%	239M
ZHEJIANG NHU COMPANY LTD.	+21.64%	8.68B
BELLRING BRANDS, INC.	-7.18%	6.71B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-16.77%	4.97B
THE SIMPLY GOOD FOODS COMPANY	-6.11%	3.66B
BYHEALTH CO., LTD	-22.96%	3.08B
XIAMEN KINGDOMWAY GROUP COMPANY	-18.62%	1.13B
HERBALIFE LTD.	-25.62%	1.13B
JAMIESON WELLNESS INC.	-1.51%	953M
USANA HEALTH SCIENCES, INC.	-11.94%	862M

Special Foods & Wellbeing Products